ACI
CO

AMP Capital Investors’s Global Cord Blood Corporation CO Stock Holding History

AMP Capital Investors’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,400
Closed -$126K – 1264
2018
Q1 		$126K Hold
12,400
– – ﹤0.01% 1149
2017
Q4 		$123K Hold
12,400
– – ﹤0.01% 1171
2017
Q3 		$138K Hold
12,400
– – ﹤0.01% 1118
2017
Q2 		$115K Buy
+12,400
New +$98.9K ﹤0.01% 1134

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SAM
Silphium Asset Management London, United Kingdom $297M AUM 28.02% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

AMP Capital Investors's CO Position: Q2 2018 in Review

AMP Capital Investors sold out of Global Cord Blood Corporation (CO) in Q2 2018, closing a stake of 12,400 shares — an estimated $126K sold.

AMP Capital Investors first reported a position in CO in Q2 2017 and held it in 4 quarters. The position peaked at $138K in Q3 2017. 46 funds tracked by Wall St. Rank hold CO as of Q2 2018.

  • AMP Capital Investors reported no remaining Global Cord Blood Corporation position as of Q2 2018 after selling out during the quarter.
  • AMP Capital Investors sold 12,400 Global Cord Blood Corporation shares in Q2 2018, an estimated $126K.
  • AMP Capital Investors first reported a position in Global Cord Blood Corporation in Q2 2017 and held it in 4 quarters.
  • AMP Capital Investors's Global Cord Blood Corporation position peaked at $138K in Q3 2017.
  • 46 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2018.

Based on AMP Capital Investors's 13F filing for Q2 2018, filed 13 Aug 2018.